Recruitment procedures for descriptive socio-economic studies in rare diseases. The BURQOL-RD project

Expert Opinion on Orphan Drugs

Volumn 3, Issue 7, 2015, Pages 759-765

  Serrano Aguilar, Pedro ^a,b,c   Linertova, Renata ^a,b,d   Posada De La Paz, Manuel ^e   Lopez Bastida, Julio ^b,f   Gonzalez Hernandez, Nerea ^b,g   Taruscio, Domenica ^h  

^a Servicio Canario de la Salud   (Spain)

^b EpiChron Research Group on Chronic Diseases   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^e Instituto de Salud Carlos III   (Spain)

^f UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

^h ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Participation; Rare diseases; Recruitment strategies; Socio economic studies

Indexed keywords

ARTICLE; BULGARIA; CAREGIVER; DESCRIPTIVE RESEARCH; FRANCE; GERMANY; HUMAN; HUNGARY; INTERNET; ITALY; MEDICAL RESEARCH; ORGANIZATION; PRIORITY JOURNAL; PROCEDURES; QUALITY OF LIFE; QUESTIONNAIRE; RARE DISEASE; RECRUITMENT PROCEDURE; SOCIOECONOMICS; SPAIN; SWEDEN; UNITED KINGDOM;

EID: 84932188437     PISSN: None     EISSN: 21678707     Source Type: Journal    
DOI: 10.1517/21678707.2015.1057499     Document Type: Article

References (32)

1. Taruscio D, Gentile AE, Evangelista T, et al. Centres of expertise and european reference networks: key issues in the field of rare diseases. The EUCERD Recommendations. Blood Transfus 2014;12(Suppl 3):s621-5
2. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions" on Rare Diseases: Europes' Challenges, (2009/C 151/02), 11 Nov 2008. Available from: http://ec.europa. eu/health/phthreats/noncom/docs/rarecomen.pdf [Last accessed 1 April 2015]
3. Griggs RC, Batshaw M, Dunkle M, et al. Clinical research for rare disease: opportunities, challenges and solutions. Mol Genet Metab 2009;96(1):20-6
4. Kinder BW, Sherman AC, Young LR, et al. Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis. Respir Med 2010;104(4):578-83
5. Gupta S, Bayoumi AM, Faughnan ME. Rare lung disease research: strategies for improving identification and recruitment of research participants. Chest 2011;140(5):1123-9.
6. Carroll R, Antigua J, Taichman D, et al. Motivations of patients with pulmonary arterial hypertension to participate in randomized clinical trials. Clin Trials 2012;9(3):348-57
7. De Ward SJ, Wilson A, Bausell H, Volz AS and Mooney K. Practical aspects of recruitment and retention in clinical trials of rare genetic diseases: the phenylketonuria (PKU) experience. J Genet Counsel 2014;23:20-8.
8. Johnson KJ, Mueller NL, Williams K, Gutmann DH. Evaluation of participant recruitment methods to a rare disease online registry. Am J Med Genet Part A 2014;164A:1686-94.
9. Schumacher KR, Stringer KA, Donohue JE, et al. Social media methods for studying rare diseases. Pediatrics 2014.133;e1345-53. Available from: http://pediatrics.aappublications.org/content/133/5/e1345.full.html [Last accessed 15 April 2015].
10. International rare diseases research consortium (IRDiRC). Available from: http://www.irdirc.org/[Last accessed 15 April 2015]
11. Global rare diseases patient registry and data repository (GRDR). Available from: http://www.grdr.info/[Last accessed 1 March 2015]
12. Caldwell PHY, Hamilton S, Tan A, Craig JC. Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med 2010;7(11):e1000368
13. Treweek S, Pitkethly M, Cook J, et al. Strategies to improve recruitment to randomised controlled trials. Cochrane Database Syst Rev 2010(4):MR000013
14. Fayter D, McDaid C, Eastwood A. A systematic review highlights threats to validity in studies of barriers to cancer ial participation. J Clin Epidemiol 2007;60(10):990e1001
15. Faurisson F. Survey of the delay in diagnosis for 8 rare diseases in Europe: EurordisCare2. European Organisation for Rare Diseases Web site. 2004. Available from: http://www. eurordis.org/sites/default/files/publications/FactSheetEurordiscare2. pdf [Last accessed 1 May 2014]
16. Linertová R, Serrano-Aguilar P, Posadade-la-Paz M, López bastida J, et al. BURQOL-RD Research Group. Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study. Health Policy 2012;108(1):19-26
17. French Ministry of Research. French national plan for rare diseases 2005-2008. Ensuring equity in the access to diagnosis, treatment and provision of care. EURORDIS. 2004.http://www.eurordis.org/IMG/pdf/ENfrenchrarediseaseplan.pdf [Last accessed 15 April 2015]
18. European Commission. Seventh Framework Program. Health.2010.2.4.4-2. ERA-Net on rare diseases (E-Rare-2). P7-ERANET-2010-RTD. Grant agreement no: 266608
19. Westermann CJ, Rosina AF, De Vries V, de Coteau PA. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A 2003;116A(4):324-8
20. Ingelfinger JR, Drazen JM. POs and research on rare diseases. N Engl J Med 2011;364(17):1670-1
21. Eurordis. The Voice of 12.000 Patients Experiences and expectations of rare disease patients on diagnosis and care in europe. Available from: www.eurordis.org 2009
22. FEDER. Estudio sobre situación de necesidades sociosanitarias de las personas con enfermedades raras en Espanã. Estudio ENSERio. Obra Social de Caja Madrid 2009
23. Lauren Limb, Stephen Nutt and Alev Sen-December 2010 Experiences of Rare Diseases: An Insight from Patients and Families. Rare Diseases UK
24. Rare Disease Impact Report: Insights from patients and the medical community. Shire 2013. Available from: http://www.shire. com/shireplc/dlibrary/documents/RareDiseaseImpactReportforWeb.pdf [Last accessed 23 March 2015]
25. Bedgood R, Sadurski R, Schade RR. The use of the internet in data assimilation in rare diseases. Dig Dis Sci 2007;52(2):307-12
26. Fox S. Peer-to-peer Healthcare [Internet]. Pew Research Center. Retrieved from http://www.pewinternet.org/~/media//Files/Reports/2011/PewP2PHealthcare2011.pdf [Last accessed in April 2013]
27. Hamilton RJ, Bowers BJ. Internet recruitment and e-mail interviews in qualitative studies. Qual Health Res 2006;16(6):821-35
28. Rhodes SD, Bowie DA, Hergenrather KC. Collecting behavioural data using the world wide web: considerations for researchers. J Epidemiol Community Health 2003;57(1):68-73
29. Abma TA. Patients as partners in a health research agenda setting. The feasibility of a participatory methodology. Evaluation & the Health Professions 2006;29(4):424-39
30. Oliver S, Clarke-Jones L, Rees R, et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. Health Technol Assess 2004;8(15):1-148
31. Whitstock MT. Seeking evidence from medical research consumers as part of the medical research process could improve the uptake of research evidence. J Eval Clin Pract 2003;9(2):213-24
32. Serrano-Aguilar P, Trujillo-Martin MM, Ramos-Goñi JM, et al. Patient involvement in health research: A contribution to a systematic review on the effectiveness of treatments for degenerative ataxias. Soc Sci Med 2009;69:920-5